Taizhou rijian Sino foreign pharmaceutical industry Co., Ltd. obtained GMP certificate

Recently, Taizhou rijian Chinese and foreign pharmaceutical industry Co., Ltd., a settled enterprise of China Pharmaceutical City, obtained the GMP certificate issued by Jiangsu drug administration, with the certification scope of sub packaging (tablet) of imported drugs, mainly engaged in the production of sub packaging of imported drugs of sigmai, and the indication is angina pectoris The company was founded in June 2016 and invested by Sino foreign pharmaceutical Co., Ltd of Japan In February 2018, the company obtained the drug production license Since Taizhou rijian Sino foreign pharmaceutical industry Co., Ltd settled in the park, its directly subordinate branches have adhered to the working principle of "no reduction in standards, no reduction in procedures, process optimization, and speed up" and the working concept of "early intervention, full participation, and all-round service" Under the premise of ensuring legal compliance and quality safety, they have taken the initiative to do a good job in relevant coordination and service work to help enterprises solve problems Problems encountered in obtaining the certificate This article is reprinted by yaozhi.com The copyright belongs to the original author The purpose of reprint is to transmit more information, which does not represent the view of this platform If the content of the work, copyright and other issues are involved, please contact our website message, we will delete the content in the first time.